Provided by Tiger Fintech (Singapore) Pte. Ltd.

DaVita HealthCare Partners

147.02
+6.664.74%
Pre-market: 149.192.17+1.48%08:00 EDT
Volume:1.10M
Turnover:160.32M
Market Cap:11.76B
PE:13.70
High:147.95
Open:139.72
Low:139.06
Close:140.36
Loading ...

3 Reasons to Sell DVA and 1 Stock to Buy Instead

StockStory
·
3 hours ago

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
08 Mar

BUZZ- Some defensives outperform, even as indexes switch to gains

Reuters
·
08 Mar

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

PR Newswire
·
06 Mar

DaVita: A Buffett-Backed Healthcare Stock Worth Watching

GuruFocus.com
·
06 Mar

DaVita Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Mar

With EPS Growth And More, DaVita (NYSE:DVA) Makes An Interesting Case

Simply Wall St.
·
04 Mar

Rap star Pusha T's 'favorite business' venture is surprisingly a US medical-based service company

Moneywise
·
01 Mar

Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

Zacks
·
28 Feb

DaVita, YMCA of the USA deepen collaboration for kidney health

TIPRANKS
·
27 Feb

Ymca of the USA Deepens Collaboration With DaVita to Drive Kidney Health Initiatives in Seven Communities

THOMSON REUTERS
·
27 Feb

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

GlobeNewswire
·
27 Feb

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
27 Feb

Berkshire Hathaway sells 750,000 DaVita shares

Reuters
·
20 Feb

Berkshire Hathaway Sells 750,000 Shares of DaVita Between February 14 and February 19, NOW Owns About 35.14 Million Shares, SEC Filing Shows

THOMSON REUTERS
·
20 Feb

DaVita Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
19 Feb